Clinical Trial

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Formulations of Subcutaneously Administered Solrikitug in Healthy Japanese and non-Japanese Participants
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-04; most recent amendment 2026-02-06.
Status change: Recruiting → Completed 2026-02-06
Status change: Not Yet Recruiting → Recruiting 2025-08-07
Trial Details
NCT Number NCT06868082
Lead Sponsor Uniquity One (UNI)
Conditions Healthy
Enrollment 32 participants
Start Date 2025-06-20
Primary Completion 2026-02-02 (estimated)
Study Completion 2026-02-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-09